Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
PulseAugur coverage of Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells — every cluster mentioning Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Reverse Item Response Theory Applied to Cancer Drug-Response Data
Researchers have developed a novel application of reverse Item Response Theory (IRT) to analyze fragmented cancer drug-response data. This method treats cancer types as latent subjects with resistance abilities and drug…
-
New multiVCBART framework enhances multivariate regression with flexible coefficient modeling
Researchers have developed multiVCBART, a novel framework for multivariate regression that jointly models outcome-specific coefficient surfaces and a sparse residual precision matrix. This approach allows predictor effe…